Clinitech Laboratory, a company specializing in diagnostic and healthcare tests and services, is launching an IPO with a fixed price issue of Rs 5.78 crores. This IPO is entirely a fresh issue of 6.02 lakh shares.
The Clinitech Laboratory IPO will be open for subscription from July 25, 2024, to July 29, 2024. The allotment is expected to be finalized on Tuesday, July 30, 2024, with the shares listing on BSE SME on Thursday, August 1, 2024.
The price for the Clinitech Laboratory IPO is set at ₹96 per share. Investors can apply for a minimum lot size of 1200 shares, requiring a minimum investment of ₹115,200 for retail investors. High Net Worth Individuals (HNIs) need to invest in a minimum of 2 lots (2,400 shares), amounting to ₹230,400.
First Overseas Capital Limited is the book-running lead manager for the Clinitech Laboratory IPO, while Bigshare Services Pvt Ltd is the registrar for the issue. The market maker for this IPO is Bhh Securities
Clinitech Laboratory IPO Details:
| Company Name | Clinitech Laboratory Limited |
| Sector | Diagnostics and Healthcare |
| IPO Type | SME |
| IPO Open date | 25th July 2024 |
| IPO Close date | 29th July 2024 |
| OFS | |
| Listing Exchanges | BSE |
| Share Holding Pre-issue | |
| DRHP Draft Prospectus | Click to check |
| RHP Draft Prospects | Click to check |
Clinitech Laboratory IPO Lot Size:
| Application | Lot Size | Shares | Amount |
| Retail (Min) | 1 | 1200 | 1,15,200 |
| HNI (Min) | 2 | 2400 | 2,30,400 |
Clinitech Laboratory IPO Timeline:
| IPO Open Date | 25th July 2024 |
| IPO Close Date | 29th July 2024 |
| Basis of Allotment | 30th July 2024 |
| Refund Initiation Date | 31st July 2024 |
| Shares Credit to Demat | 31st July 2024 |
| Listing Date | 1st August 2024 |
Things to Consider before applying for an IPO
Financial Performance: Review Clinitech Laboratory’s financials to understand its revenue, profitability, and growth prospects.
Industry Outlook: Consider the overall health of India’s Diagnostics and Healthcare industry.
Valuation: Compare the price band to similar companies in the industry to see if the IPO is priced fairly.
Management Team: Research the experience and capabilities of the management team.
Our Verdict
This IPO offers a good opportunity to invest in Clinitech Laboratory and be a part of its growth. We will update our verdict once the IPO application window opens
FAQ
What is Grey Market Premium (GMP)?
The Grey Market Premium (GMP) represents the price at which an Initial Public Offering (IPO) is traded in the unregulated grey market before its official listing. It serves as an indicator of how the IPO might perform on the listing day. Seeing the latest GMP, investors can estimate the listing performance of the IPO.
